Corcept Therapeutics (CORT) Current Taxes (2017 - 2018)

Corcept Therapeutics' (CORT) quarterly Current Taxes came in at $1.6 million in Q3 2018, up 130.42% quarter-over-quarter from $687000.0 in Q2 2018.

Corcept Therapeutics (CORT) Current Taxes (2017 - 2018) Analysis & Trends

Corcept Therapeutics has disclosed Current Taxes across 2 years of filings, most recently posting $1.6 million for Q3 2018.

Current Taxes for Q3 2018 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $1.6 million (changed N/A YoY), and the FY2017 annual result was $66000.0, changed N/A from the prior year.
Current Taxes came in at $1.6 million for Q3 2018 at Corcept Therapeutics, up from $687000.0 in the prior quarter.
In the past five years, Current Taxes ranged from a high of $1.6 million in Q3 2018 to a low of $66000.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	10,460.56
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	19.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Corcept Therapeutics	8.35 Bn	8.01 Bn	162.02 Mn	-

Download Data